Monday’s lawsuits from Eli Lilly are the first to be filed by the pharma since the regulator officially removed tirzepatide ...
The American Heart Association and the American Stroke Association issued guidelines Monday that also look at the effects of testosterone and estrogen on the body. Meanwhile, Eli Lilly sues three ...
Lilly has already sued more than two dozen medical spas, wellness centers and compounding pharmacies for selling products ...
Eli Lilly said on Monday it sued three medical spas and online vendors for selling products claiming to contain tirzepatide, ...
Eli Lilly sues vendors for selling unauthorized tirzepatide amid resolved shortages. Lawsuits target vendors offering ...
The lawsuit singles out Pivotal Peptides, MangoRx and Genesis Lifestyle Medicine for either offering research-grade meds ...
Eli Lilly sued three medical spas and online vendors for selling products that claim to contain the ingredient in its ...
The new lawsuits, which name Pivotal Peptides, MangoRx and Genesis Lifestyle Medicine of Nevada, are the first related to ...
A trade group for large compounding pharmacies sued the FDA over its move to take Eli Lilly’s blockbuster GLP-1 drug off its shortage list, hamstringing … ...
With an estimated 2 million people in the United States taking copycat versions of Eli Lilly and Novo Nordisk ... particularly online, and have surged in popularity as demand for the treatments ...
A group representing companies that produce copycat versions of Eli Lilly weight loss medications has filed a lawsuit against the FDA following the agency's recent decision to remove the drugs ...
Eli Lilly (NYSE: LLY) stock has climbed in the double digits over the past year thanks to its leading position in one of the highest-growth pharmaceutical markets around: weight loss drugs.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback